tiprankstipranks
Abivax SA (GB:0RA9)
LSE:0RA9

Compare Abivax SA (0RA9) vs. Competitors

0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Abivax SA
€107.70
€8.56B
-24.91
2102.45%
2 Buy
0 Hold
0 Sell
Moderate Buy
Innate Pharma SA
€1.62
€109.00M
-1.31
-32.44%
DBV Technologies
€3.50
€975.14M
-3.62
181.22%
1 Buy
0 Hold
1 Sell
Hold
Transgene
€0.94
€217.09M
-3.69
21.96%
Valneva
€2.68
€460.34M
-5.43
-4.46%
1 Buy
0 Hold
0 Sell
Moderate Buy
Cellectis SA
€3.86
€230.57M
-7.03
172.48%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GB:0RA9
Abivax SA
107.70
102.49
1967.18%
FR:IPH
Innate Pharma SA
1.16
-0.58
-33.10%
FR:DBV
DBV Technologies
3.50
2.19
165.66%
FR:TNG
Transgene
0.78
0.14
21.96%
FR:VLA
Valneva
2.68
-0.52
-16.20%
FR:ALCLS
Cellectis SA
3.19
1.77
124.82%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts